MLLCF vs REGN: Which Stock is Better?

Side-by-side comparison of Molecular Partners AG and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

MLLCF

Molecular Partners AG

$3.50

REGN

Regeneron Pharmaceuticals Inc

$733.78

Key Metrics Comparison

MetricMLLCFREGNWinner
Market Cap$132.00M$77.69BREGN
P/E RatioN/A17.57REGN
EPS (TTM)$N/A$41.71REGN
Revenue Growth-1.0%0.0%REGN
Gross Margin0.0%45.8%REGN

Analyze MLLCF

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is MLLCF or REGN a better investment?

Comparing MLLCF and REGN: Molecular Partners AG has a market cap of $132.00M while Regeneron Pharmaceuticals Inc has $77.69B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between MLLCF and REGN?

MLLCF (Molecular Partners AG) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: MLLCF or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: MLLCF or REGN?

REGN has higher revenue growth at 0.0% vs -1.0% for MLLCF.

Which company is more profitable: MLLCF or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 45.8% compared to 0.0% for MLLCF.

Which is the larger company: MLLCF or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.69B compared to $132.00M for MLLCF.

Should I buy MLLCF or REGN in 2026?

Both MLLCF and REGN have investment merit. MLLCF trades at $3.50 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between MLLCF and REGN stock?

Key differences: Market Cap ($132.00M vs $77.69B), P/E Ratio (N/A vs 17.6x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (0.0% vs 45.8%).

Popular Stock Comparisons